You are here: Industry Insights > Market News > In discussions with India for vaccine supply: Pfizer

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

In discussions with India for vaccine supply: Pfizer

expresspharmaApril 23, 2021

Tag: Pfizer , India , COVID-19 Vaccine

Favorites

Pfizer is in discussions with India and committed to make its COVID-19 vaccine available for deployment in the country, the company said.

The company said it had offered India a not-for-profit price for its vaccine for the government’s immunisation programme.

Previous:Valneva’s Inactivated, Adjuvanted COVID-19 Vax Achieves Positive Data

Next:Monoclonal antibodies against COVID-19 have high potential, but efficacy against emerging variants muddled: GlobalData

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

PharmaSourcesMay 16, 2024

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Biotech NewswireMay 14, 2024

In discussions with India for vaccine supply: Pfizer | Pharmasources.com

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

Biotech NewswireMay 10, 2024

Nucleic Acid Medicines Manufacture, Round 2 call.

In discussions with India for vaccine supply: Pfizer

Related News

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

You may like